ArticleCancer immunology, immunotherapy : CII2021

Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models.

Chi-Ping Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.